Featured Firms
Presented by BigVoodoo
Federal Trade Commissioner Jon Leibowitz has called for a study into whether the licensing of "authorized generic" drugs by brand-name makers is inhibiting production of low-cost alternatives by generic makers. The issue is of critical significance to generics companies, which operate in a cutthroat and low-margin sector. Big Pharma is increasingly doing deals with friendly generics companies that are structured to deprive large generics makers of some profits during the coveted exclusivity period.
May 16, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS